Skip to content

Effectiveness of dextrose prolotherapy in the treatment of knee osteoarthritis: a randomized controlled trial

Effectiveness of dextrose prolotherapy in the treatment of knee osteoarthritis: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPC-15006617
Enrollment
Unknown
Registered
2015-06-17
Start date
2015-06-30
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Group 1:Intra-articular dextrose injection 16 weeks
Group 2:Intra-articular normal saline injection 16 weeks

Sponsors

Professor Regina Wing Shan SIT
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. To be aged from 45 to 75 years old; 2. Diagnosis of knee OA based on clinical criteria as defined by the American Rheumatology Association; 3. Have experienced moderate to severe anterior knee pain for at least 3 months, defined as a score of 3 or more (0-6 ordinal response scale) on the question "What is the average level of your left/right knee pain?" 4. Failed 6 months of usual care.

Exclusion criteria

Exclusion criteria: 1. History of corn allergy; 2. Previous operation either open or arthroscopic, on the referring knee; 3. Pregnancy; 4. Body mass index >=35 kg/m2; 5. Patients on anti-coagulant therapy; 6. Prior knee prolotherapy; 7. Any knee injections within 3 months; 8. Inflammatory or post-infectious knee arthritis; 9. Significant effusion as defined by a balotteable patella; 10. Co-morbidity severe enough to prevent participation in the study protocol like attendance at scheduled injection appointments.

Design outcomes

Primary

MeasureTime frame
(1) WOMAC score of both intervention and control group;

Secondary

MeasureTime frame
(2) VAS 0-100 mm;(3) 30 second chair stand performance test;(4) timed up and go test;(5) EQ5;(6) the pattern of analgesic consumption with the statement "I take analgesic drugs like (name of analgesics) daily, as needed, none at all.";(7) treatment satisfaction will be assessed at 52 weeks with the question “Will you recommend the therapy to others with knee OA like yours? (yes/no)”.;40 meter fast-paced walk test;

Countries

China

Contacts

Public ContactProfessor Regina Wing Shan SIT

Division of Family Medicine and Primary Health Care, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong

reginasit@cuhk.edu.hk+852 25039053

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 6, 2026